(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -10.31%20.39B | -3.15%98.94B | -6.80%73.92B | -13.10%48.98B | -14.46%22.74B | -10.27%102.15B | -7.58%79.31B | -0.87%56.37B | 11.28%26.58B | 39.50%113.85B |
Operating income | -10.31%20.39B | -3.15%98.94B | -6.80%73.92B | -13.10%48.98B | -14.46%22.74B | -10.27%102.15B | -7.58%79.31B | -0.87%56.37B | 11.28%26.58B | 39.50%113.85B |
Operating expenses | 11.63%-20.07B | 1.56%-97.31B | 3.43%-73.07B | 5.88%-49.52B | 7.10%-22.71B | 3.36%-98.85B | -4.77%-75.67B | -10.85%-52.62B | -15.51%-24.44B | -37.52%-102.29B |
Gross profit | 1,065.62%323.66M | -50.72%1.63B | -76.84%843.24M | -114.48%-543.03M | -98.70%27.77M | -71.40%3.31B | -73.20%3.64B | -60.09%3.75B | -21.57%2.14B | 59.90%11.56B |
Selling expenses | -13.12%-75.77M | -15.62%-341.24M | -19.67%-265.28M | -38.47%-177.9M | -14.36%-66.98M | 1.66%-295.13M | -8.21%-221.67M | -1.20%-128.48M | -3.09%-58.57M | -14.14%-300.1M |
Administrative expenses | -14.77%-203.33M | 26.14%-933.38M | 38.60%-654.55M | 27.44%-456.38M | 18.64%-177.15M | 9.00%-1.26B | 9.11%-1.07B | 11.06%-628.97M | -54.46%-217.73M | 8.43%-1.39B |
Research and development expenses | 14.91%-227.79M | -5.46%-1.23B | 0.22%-914.29M | 3.01%-643.42M | 16.21%-267.7M | -1.64%-1.17B | 72.48%-916.26M | 67.58%-663.42M | 41.79%-319.49M | 36.66%-1.15B |
Profit from asset sales | 258.20%60.46M | -78.68%93.86M | -94.87%21.54M | -95.99%16.88M | -87.06%16.88M | 96.81%440.34M | 2,438.07%419.84M | 34,389.11%420.58M | 1,630.25%130.44M | -62.02%223.74M |
Revaluation surplus | 93.23%-1.6M | -214.91%-34.56M | -138.41%-34.56M | -161.30%-34.56M | -187.55%-23.62M | -64.52%30.08M | 4.04%89.96M | -14.42%56.38M | -30.81%26.98M | 216.62%84.77M |
-Changes in the fair value of other assets | 93.23%-1.6M | -214.91%-34.56M | -138.41%-34.56M | -161.30%-34.56M | -187.55%-23.62M | -64.52%30.08M | 4.04%89.96M | -14.42%56.38M | -30.81%26.98M | 216.62%84.77M |
Impairment and provision | -93.14%3.32M | 37.48%-953.86M | 18.75%-636.52M | 21.81%-631.09M | 399.09%48.36M | -14.37%-1.53B | -6,717.82%-783.43M | -2,342.40%-807.12M | -32.01%9.69M | -62.87%-1.33B |
-Other impairment is provision | -93.14%3.32M | 37.48%-953.86M | 18.75%-636.52M | 21.81%-631.09M | 399.09%48.36M | -14.37%-1.53B | -6,717.82%-783.43M | -2,342.40%-807.12M | -32.01%9.69M | -62.87%-1.33B |
Special items of operating profit | 101.01%150.24M | 3.59%1.02B | -25.39%530.41M | -4.75%504.45M | -64.01%74.75M | 2.80%986.93M | -1.02%710.87M | 18.05%529.61M | -1.72%207.66M | 54.69%960.05M |
Operating profit | 77.21%-105.66M | -3,273.72%-1.13B | -193.66%-1.43B | -196.15%-2.18B | -125.54%-463.72M | -99.56%35.51M | -83.35%1.52B | -65.78%2.27B | -12.97%1.82B | 133.87%8B |
Financing cost | -101.69%-155.06M | 10.12%-466.91M | 29.02%-318.29M | 44.78%-178.96M | 14.68%-76.88M | 17.77%-519.46M | 8.34%-448.39M | 15.49%-324.1M | 62.93%-90.11M | -14.12%-631.75M |
Special items of earning before tax | -479.91%-3.79M | 96.25%-2.88M | 103.21%2.36M | 101.72%1.27M | 103.87%997.36K | 78.19%-76.67M | -345.45%-73.62M | -340.39%-73.69M | -256.19%-25.8M | -264.36%-351.59M |
Earning before tax | 50.98%-264.51M | -184.80%-1.6B | -273.99%-1.74B | -226.05%-2.36B | -131.74%-539.61M | -107.99%-560.62M | -88.48%1B | -70.19%1.87B | -8.60%1.7B | 127.74%7.02B |
Tax | -85.03%-81.12M | 83.28%-43.24M | 68.80%-101.46M | 72.03%-72.05M | 88.38%-43.84M | 74.70%-258.63M | 79.58%-325.2M | 79.32%-257.57M | -72.25%-377.17M | -103.30%-1.02B |
After-tax profit from continuing operations | 40.76%-345.64M | -100.17%-1.64B | -372.60%-1.84B | -250.60%-2.43B | -144.11%-583.45M | -113.67%-819.24M | -90.47%676.69M | -67.93%1.62B | -19.39%1.32B | 132.51%5.99B |
Earning after tax | 40.76%-345.64M | -100.17%-1.64B | -372.60%-1.84B | -250.60%-2.43B | -144.11%-583.45M | -113.67%-819.24M | -90.47%676.69M | -67.93%1.62B | -19.39%1.32B | 132.51%5.99B |
Minority profit | 53.30%-34.64M | -915.01%-312.74M | -2,115.79%-246.84M | -205.15%-197.89M | -206.99%-74.18M | -94.20%38.37M | -97.87%12.25M | -52.24%188.21M | -46.69%69.33M | 11.15%661.72M |
Profit attributable to shareholders | 38.93%-311M | -54.75%-1.33B | -340.48%-1.6B | -256.59%-2.24B | -140.63%-509.27M | -116.08%-857.62M | -89.82%664.45M | -69.26%1.43B | -17.04%1.25B | 168.95%5.33B |
Basic earnings per share | 42.86%-0.04 | -49.91%-0.1724 | -340.44%-0.2075 | -256.07%-0.2892 | -143.75%-0.07 | -116.61%-0.115 | -89.82%0.0863 | -69.27%0.1853 | -20.00%0.16 | 168.89%0.6924 |
Diluted earnings per share | 42.86%-0.04 | -49.91%-0.1724 | -340.44%-0.2075 | -256.07%-0.2892 | -143.75%-0.07 | -116.61%-0.115 | -89.82%0.0863 | -69.27%0.1853 | -20.00%0.16 | 168.89%0.6924 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data